The prescribing of every single brand and strength of opioid funded by taxpayers will be reviewed by a PBAC expert committee…
Read more
There was little growth in government expenditure on PBS medicines in the last financial year, according to the latest PBS…
Read more
The PBAC has declared budesonide-formoterol combination inhalers should be funded as a first-line treatment for mild asthma…
Read more
The countdown continues. Is the blue inhaler, that medicine cabinet regular, making its last gasp? And should 'sticks that…
Read more
As another year draws to a close, Pharmacy News is revisiting some of the most popular stories for 2019. Here’s our Top 10:…
Read more
The antibiotic resistance threat is real. In the years to come, we will no longer be able to treat and cure many infections…
Read more
The number of patients with metastatic non-small cell lung cancer eligible for subsidised treatment with pembrolizumab is…
Read more